Concepedia
Statistics
Publications
7
Citations
413
H-Index
Active since
2016
Affiliations
Takeda (Japan)(Current)
Ayumi Ando is an author at Takeda (Japan) specializing in medicine, oncology, and tumor metabolism.
Publications per year
2016–2019
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
Akito Nakamura, Tadahiro Nambu, Shunsuke Ebara et al. · Proceedings of the National Academy of Sciences · 2018 · 170 citations · Full text
Medicine, Oncology, Pharmacology +16
Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditions
Saomi Murai, Ayumi Ando, Shunsuke Ebara et al. · Oncogenesis · 2017 · 81 citations · Full text
Life Sciences, Cancer Biology, Oncology +17
Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors
Takatsugu Okegawa, Megumi Morimoto, Satoru Nishizawa et al. · EBioMedicine · 2017 · 68 citations · Full text
Medicine, Cancer Biology, Oncology +17
Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors
Satoshi Kitazawa, Shunsuke Ebara, Ayumi Ando et al. · Oncotarget · 2017 · 34 citations · Full text
Medicine, Oncology, Pharmacology +15
A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models
Y. Kawata, Shoki Okuda, Natsu Hotta et al. · European Journal of Pharmacology · 2016 · 24 citations
Medicine, Endocrinology, Pharmacology +15
1–5 of 7